Illicit narcotics pose severe and interlocking public health, security, environmental, and economic challenges for the United States and worldwide. As drug production and consumption habits shift, policymakers have found themselves amid a lengthy transitionary period wherein narcotics policy must simultaneously grapple with the burgeoning threat of synthetic drugs, most notably fentanyl and its analogues, while managing still-surging production of plant-based drugs such as cocaine and heroin. Addressing these challenges effectively therefore requires a comprehensive approach, alongside close cooperation with allies and partners.
This event will feature Dr. Rahul Gupta, Director of the Office of National Drug Control Policy (ONDCP) for a conversation on the future of U.S. counter-narcotics policy in a shifting geopolitical and security landscape. During the conversation, Dr. Gupta will outline ONDCP’s strategic approach of commercial disruption and how to navigate this transition period, and what this means for efforts to tackle the most salient challenges posed by illicit drugs and the transnational criminals which traffic them.
This event is made possible through general support to CSIS.